The effect of risankizumab on achieving minimal clinically important differences in patient-reported outcomes in patients with psoriatic arthritis: results from KEEPsAKE 1 and 2
L E Kristensen, A M Soliman, K Papp, L Barcomb, A Eldred, A Östör
Dyk ned i forskningsemnerne om 'The effect of risankizumab on achieving minimal clinically important differences in patient-reported outcomes in patients with psoriatic arthritis: results from KEEPsAKE 1 and 2'. Sammen danner de et unikt fingeraftryk.